Evidence map›Paper›PMID 35044299›Full record

ArticleeLife2022

Differential regulation of cranial and cardiac neural crest by serum response factor and its cofactors.

Colin J Dinsmore, Philippe Soriano

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Serum response factor as a prognostic indicator of angiogenesis and early recurrence in Glioblastoma: a retrospective immunohistochemical study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Colin J DinsmoreDepartment of Cell, Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, United States.ORCID 0000-0002-6404-1202
Philippe SorianoDepartment of Cell, Development and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, United States.ORCID 0000-0002-0427-926X
Icahn School of Medicine at Mount Sinai · US

Funding

Growth Factor Signaling and Craniofacial DevelopmentR01DE022363 · NIDCR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SORIANO, PHILIPPE M · 2012 to 2022
$6.4M
SRF Modularity During Craniofacial DevelopmentF32DE026678 · NIDCR · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DINSMORE, COLIN J · 2016 to 2019
$185k
NIDCR NIH HHS F32 DE026678NIDCR NIH HHS R01 DE022363
6 · The paper itself

Abstract

Serum response factor (SRF) is an essential transcription factor that influences many cellular processes including cell proliferation, migration, and differentiation. SRF directly regulates and is required for immediate early gene (IEG) and actin cytoskeleton-related gene expression. SRF coordinates these competing transcription programs through discrete sets of cofactors, the ternary complex factors (TCFs) and myocardin-related transcription factors (MRTFs). The relative contribution of these two programs to in vivo SRF activity and mutant phenotypes is not fully understood. To study how SRF utilizes its cofactors during development, we generated a knock-in

Indexed as

AnimalsMiceNeural CrestSerum Response FactorTernary Complex FactorsTranscription FactorsSerum Response FactorSrf protein, mouseTernary Complex FactorsTranscription Factorscraniofacial developmentdevelopmental biologymouseMRTFneural crestSRFTCFtranscription

Identifiers

PMID35044299
PMCPMC8806183
OpenAlexW4205206414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.